The global label free detection market size is growing significantly due rise in contract research organization in emerging economies, and increasing government funding and grants in the industry. Increasing drug discovery programs through research partnerships between pharmaceutical companies and academic institutes are also supporting the growth of the market. Massive unexplored market in label free detection industry of developing economies are creating significant opportunities for the label free detection market to grow during the forecasted period.
The label free detection market is categorized on the basis of technology, application, products and end users. On the basis technology of label free detection, the market can be categorized as optical waveguide grating technology, surface plasmon resonance, cellular dielectric spectroscopy, bio-layer interferometry and others technologies. Surface plasmon resonance leads the market, as this technology is highly employed in drug discovery and development for getting into molecular binding mechanism and biological processes. Whereas, bio-layer interferometry is expected to grow at fastest rate due to increasing usage of technology in lifescience research for ligand binding studies. Based on application, the label free detection market can be segmented as lead generation, binding kinetics, hit confirmation, endogenous receptors detection, binding thermodynamics, and others.
Download sample copy of this report at: https://www.psmarketresearch.com/market-analysis/label-free-detection-market/report-sample
Some of the factors driving the growth of label free detection market are increasing research and development budgets of pharmaceutical companies, increasing pharmaceutical outsourcing, increasing biomolecular interaction analysis in drug discovery, intrinsic advantages of label free detection over alternative technologies, such as flow cytometry, and ELISA, and increasing drug discoveries programs. However, lack of skilled professionals, and high cost of instruments are some of the factors restraining the growth of the global label free detection market.
Some of the companies operating in the global label free detection market are Pall Corporation, Roche Diagnostics, Bio-Rad Laboratories, Inc., General Electric, X-Body Biosciences, Ametek, Inc., Bioptix, Corning, Inc., Attana AB, Danaher Corporation, and Perkinelmer, Inc.
This post was originally published on Financial Sector